Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3767998014 | Imipenem anhydrous (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3767999018 | Imipenem anhydrous | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Imipenem anhydrous (substance) | Is a | Carbapenem (substance) | true | Inferred relationship | Some | ||
| Imipenem anhydrous (substance) | Is a | Substance with beta-lactam structure and antibacterial mechanism of action (substance) | true | Inferred relationship | Some | ||
| Imipenem anhydrous (substance) | Has disposition (attribute) | Antibacterial (disposition) | true | Inferred relationship | Some | ||
| Imipenem anhydrous (substance) | Is modification of (attribute) | Imipenem | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has basis of strength substance (attribute) | True | Imipenem anhydrous (substance) | Inferred relationship | Some | 1 |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Has basis of strength substance (attribute) | True | Imipenem anhydrous (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR